Parmax Pharma Ltd

📅 Parmax Pharma to Review Q3 & 9M FY2025 Results on Feb 14, 2026

- Board meeting scheduled for February 14, 2026 to approve unaudited financial results for Q3 and nine months ended December 31, 2025.

- Trading window for company securities closed until 48 hours after results announcement.